Literature DB >> 17198853

Population-based study of early age-related macular degeneration: role of the complement factor H Y402H polymorphism in bilateral but not unilateral disease.

Nicole Tedeschi-Blok1, Jonathan Buckley, Rohit Varma, Timothy J Triche, David R Hinton.   

Abstract

OBJECTIVE: Recently, a strong association has been observed for the complement factor H (CFH) Tyr402His polymorphism with early and advanced age-related macular degeneration (AMD) in independent non-Hispanic White, clinic-based, case-control studies. These studies suggest the CFH His402 allele is a major risk allele in early and advanced AMD, explaining 43% to 70% of all AMD in older adults. We utilized a population-based case-control study design of early AMD among Latinos/Hispanics to evaluate the CFH Tyr402His polymorphism for an association with early AMD phenotypes.
DESIGN: Retrospective population-based case-control study. PARTICIPANTS: This study cohort consists of 285 early AMD cases and 570 controls matched on age, birthplace, and smoking status.
METHODS: Genotype determination was performed by allele-specific digestion of polymerase chain reaction products. MAIN OUTCOME MEASURES: Complement factor H Tyr402His polymorphism.
RESULTS: We observed no overall statistically significant association with early AMD among Latinos. However, a subset of early AMD cases that have bilateral, not unilateral, intermediate-to-large soft macular drusen were 1.7 times more likely to carry either the homozygous or heterozygous His402 genotype.
CONCLUSIONS: Our data suggest that the CFH Tyr402His is not a major risk factor for overall early AMD in this Latino population, but may play a role in susceptibility to phenotypes of early AMD likely to progress to late AMD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198853     DOI: 10.1016/j.ophtha.2006.07.043

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

Review 1.  Complement pathway biomarkers and age-related macular degeneration.

Authors:  M Gemenetzi; A J Lotery
Journal:  Eye (Lond)       Date:  2015-10-23       Impact factor: 3.775

2.  Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study.

Authors:  Farzana Choudhury; Rohit Varma; Roberta McKean-Cowdin; Ronald Klein; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2011-06-16       Impact factor: 5.258

3.  The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration.

Authors:  Martha Dietzel; Daniel Pauleikhoff; Astrid Arning; Britta Heimes; Albrecht Lommatzsch; Monika Stoll; Hans-Werner Hense
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-28       Impact factor: 3.117

4.  Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study.

Authors:  Nicole A Restrepo; Kylee L Spencer; Robert Goodloe; Tiana A Garrett; Gerardo Heiss; Petra Bůžková; Neal Jorgensen; Richard A Jensen; Tara C Matise; Lucia A Hindorff; Barbara E K Klein; Ronald Klein; Tien Y Wong; Ching-Yu Cheng; Belinda K Cornes; E-Shyong Tai; Marylyn D Ritchie; Jonathan L Haines; Dana C Crawford
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-09       Impact factor: 4.799

5.  Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Frank S Ong
Journal:  Expert Rev Ophthalmol       Date:  2013-04-01

6.  Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study.

Authors:  Rohit Varma; Athena W P Foong; Mei-Ying Lai; Farzana Choudhury; Ronald Klein; Stanley P Azen
Journal:  Am J Ophthalmol       Date:  2010-05       Impact factor: 5.258

7.  Histopathology of Age-Related Macular Degeneration and Implications for Pathogenesis and Therapy.

Authors:  Ru-Ik Chee; Abdallah Mahrous; Lisa Koenig; Lindsay Skye Mandel; Fahd Yazdanie; Chi-Chao Chan; Mrinali P Gupta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  The ARMS2 A69S variant and bilateral advanced age-related macular degeneration.

Authors:  Stephen G Schwartz; Anita Agarwal; Jaclyn L Kovach; Paul J Gallins; William Cade; Eric A Postel; Gaofeng Wang; Juan Ayala-Haedo; Kylee M Spencer; Jonathan L Haines; Margaret A Pericak-Vance; William K Scott
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

9.  Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

10.  An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism.

Authors:  Bareng A S Nonyane; Dorothea Nitsch; John C Whittaker; Reecha Sofat; Liam Smeeth; Usha Chakravarthy; Astrid E Fletcher
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.